A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV … LK Dropulic, MC Oestreich, HL Pietz, KJ Laing, S Hunsberger, K Lumbard, ... The Journal of infectious diseases 220 (6), 990-1000, 2019 | 50 | 2019 |
A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis MC Carter, I Maric, EH Brittain, Y Bai, K Lumbard, H Bolan, D Cantave, ... Journal of Allergy and Clinical Immunology, 2020 | 29 | 2020 |
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model A Han, L Czajkowski, LA Rosas, A Cervantes-Medina, Y Xiao, ... Clinical Infectious Diseases, 2020 | 27 | 2020 |
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis YL Xie, VR de Jager, RY Chen, LE Dodd, P Paripati, LE Via, D Follmann, ... Science Translational Medicine 13 (579), 2021 | 26 | 2021 |
Prevalence and diagnosis of sesame allergy in children with IgE-mediated food allergy K Sokol, M Rasooly, C Dempsey, S Lassiter, W Gu, K Lumbard, ... Pediatric allergy and immunology: official publication of the European …, 2020 | 22 | 2020 |
Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics FL Kuang, BF Curtin, H Alao, B Piligian, A Berry, N Holland-Thomas, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2718-2726. e2, 2020 | 18 | 2020 |
Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests MP Fay, K Lumbard Statistics in Medicine 40 (5), 1147-1159, 2021 | 16 | 2021 |
Post-treatment Lyme disease symptoms score: Developing a new tool for research SP Turk, K Lumbard, K Liepshutz, C Williams, L Hu, K Dardick, ... PloS one 14 (11), e0225012, 2019 | 16 | 2019 |
Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area A Gouel-Cheron, K Lumbard, S Hunsberger, FJ Arteaga-Cabello, J Beigel, ... Antiviral research 172, 104638, 2019 | 11 | 2019 |
Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective … S Hunsberger, AM Ortega-Villa, JH Powers III, HAR León, SC Sosa, ... International Journal of Infectious Diseases 98, 241-248, 2020 | 10 | 2020 |
Using multiple data streams to estimate and forecast SARS-CoV-2 transmission dynamics, with application to the virus spread in Orange County, California. J Fintzi, D Bayer, I Goldstein, K Lumbard, E Ricotta, S Warner, LM Busch, ... Arxiv, arXiv: 2009.02654 v1-arXiv: 2009.02654 v1, 2020 | 8 | 2020 |
Exact 2x2: exact tests and confidence intervals for 2x2 tables MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard R package version 1 (6), 2021 | 7 | 2021 |
A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE) A Boulougoura, E Gabriel, E Laidlaw, V Khetani, K Arakawa, J Higgins, ... Open forum infectious diseases 6 (6), ofz246, 2019 | 5 | 2019 |
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine K Wang, L Dropulic, J Bozekowski, HL Pietz, S Jegaskanda, K Dowdell, ... The Journal of Infectious Diseases, 2021 | 3 | 2021 |
Noninferiority testing with censoring when the event rate is low SK Gallagher, J Wang, K Lumbard, LE Dodd, M Proschan Statistics in Medicine 41 (25), 5102-5112, 2022 | 1 | 2022 |
Exact Tests and Confidence Intervals for 2x2 Tables MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard | 1 | 2020 |
Half blind superiority tests for clinical trials of anti‐infective drugs D Follmann, E Brittain, K Lumbard Statistics in medicine 38 (1), 31-43, 2019 | 1 | 2019 |
Package ‘exact2x2’ MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard, MMP Fay | | 2024 |
Semi-parametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence data D Bayer, IH Goldstein, J Fintzi, K Lumbard, E Ricotta, S Warner, LM Busch, ... ArXiv, 2023 | | 2023 |
exact2x2-package: Exact Tests and Confidence Intervals for 2x2 Tables MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard | | 2020 |